查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1133518

全球电刺激器市场-2022-2029

Global Electric Stimulation Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

脊髓损伤电刺激的创新有望推动市场增长。

功能性电刺激 (FES) 是一种 NMES，它向瘫痪的神经细胞和肌肉提供电刺激，以刺激肌肉活动以执行功能性任务。 FES 广泛用于脊髓损伤 (SCI) 后的康復，主要用于恢復肢体功能。 FES 提高了强度生产和抵抗力。 FES 有助于脊髓损伤后上肢功能的恢復。 FES 还用于下肢康復，以增强步行特性，例如脚拉加速度、摆动力和地面衝击力，从而加快步行速度和更有效的步行肌肉系统。因此，当前医疗保健服务的发展正在刺激对门诊提供 FES 策略的研究。

一种解决方案是来自 Myant（加拿大多伦多）的服装刺激技术。这种服装将布料与银线或导电层结合在一起，并在服装中嵌入电极以提供电刺激。与其他解决方案相比，这些可穿戴服装应该是可调节的、具有成本效益的、多功能的、耐用的，并且能够由患者独立应用。因此，从上述陈述来看，预计市场将在预测期内受到驱动。

与物理治疗相关的高成本和严格的设备许可阻碍了市场增长。

物理治疗的高成本限制了设备的可接受性。冗长的审批流程会导致新产品的上市延迟。严格的设备许可规定和电刺激系统替代品的广泛选择是预计在预测期内阻碍市场的因素。

COVID-19 影响分析

COVID-19 大流行是人类在上个世纪面临的最具破坏性的健康危机。缺乏可行的药物选择正在阻碍与这种疾病的斗争。基于可靠的发现，电刺激可能是目前可用的对症和抗病毒药物的可行辅助手段。在临床前研究中，电刺激已被证明可有效改善呼吸功能、抑制 SARS-CoV-2 的生长、缓解疼痛、增强免疫力和提高抗病毒药物的渗透性。而且，NMES是一种简单、无创的肌肉强化治疗，一般耐受性好，无副作用，需要很少或不需要患者干预，而且相对便宜，它有一个特点。因此，NMES 疗法对 COVID-19 患者身体和肌肉功能的疗效可以系统地纳入重症监护后综合征患者的 ICU 后康復方案中。

全球电子刺激器市场报告提供大约 45 多个市场数据表、40 多个数字和 180 页结构。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因子
    • 驱动程序
      • 瘫痪患者神经刺激器的创新有望推动市场增长。
    • 约束因素
      • 预计严格的设备许可规定会阻碍市场增长。
    • 机会
    • 影响分析

第五章行业分析

  • 波特的五种力量
  • 未满足的需求
  • 供应链
  • 定价分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按设备类型

  • 脊髓刺激器
  • 深部脑刺激器
  • 迷走神经刺激器
  • □神经刺激器
  • 胃刺激器
  • 经皮神经电刺激器
  • 神经肌肉电刺激器
  • 颅内电刺激器
  • 其他

第 8 章. 按应用程序

  • 疼痛管理
  • 神经系统和运动系统疾病的治疗
  • 肌肉骨骼疾病管理
  • 新陈代谢和消化系统管理
  • 失禁管理
  • 其他

第 9 章，最终用户

  • 医院
  • 专科诊所
  • 神经外科中心
  • 门诊手术中心
  • 其他

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第 12 章公司简介

  • Boston Scientific Corporation
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • Cyberonics, Inc
  • Colfax Corporation（DJO Global, Inc.）
  • Medtronic plc
  • Nevro Corporation
  • Abbott
  • NeuroMetrix, Inc.
  • BTL Industries, Inc.
  • Cogentix Medical Inc.
  • Zynex Inc.

第13章 全球电刺激设备市场-DataM

简介目录
Product Code: DMMD1062

Market Overview

Electric Stimulation Devices Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 9.42% during the forecast period (2022-2029).

Electrical stimulators are small electronic devices that patients wear and attach to their skin via electrodes. Electrical stimulators are used for a variety of purposes, including the reduction of acute post-operative pain and swelling, the treatment of chronic intractable pain, the maintenance of muscle tone during temporary extremity immobilization, the reduction of spasticity, and the assistance of spinal cord injured patients to grasp, stand, and walk independently. e stimulation device's lead wires and electrodes are attached to the skin over the target area of the body. Electrical stimulators are also utilized at home by patients.

Market Dynamics

Innovations in electrical stimulation for spinal cord injuries are expected to drive market growtth.

Functional electrical stimulation (FES) is a form of NMES that involves administering electrical stimuli to paralyzed neurons or muscles to stimulate muscular activity to fulfill a functional task. FES is used extensively in rehabilitation following a spinal cord injury (SCI), mostly to regain extremities function. FES has boosted muscle power production and resistance. FES aids in the recovery of upper extremity function following SCI. FES has also been utilized in lower extremity rehabilitation to increase gait characteristics such as foot-pulling acceleration, swing power, and ground impact force, resulting in faster walking speeds and a more efficient system of muscle strength for gait. Therefore, current developments in healthcare delivery have stimulated research into strategies to deliver FES on an outpatient basis.

One solution is Myant's garment-based stimulation technology (Toronto, Canada). These garments combine cloth with silver thread or conductive layers to implant electrodes into the clothing to deliver electrical stimulation. Compared to other solutions, these wearable garments should be adjustable, cost-effective, multifunctional, and durable and allow for independent application by the patient. Thus, from the above statements, the market is expected to drive in the forecast period.

High costs and stringent device licensingare associated with physiotherapy treatments will hamper the market growth

High costs are associated with physiotherapy treatments, resulting in limited device acceptability. Long approval processes are causing delays in introducing new items to the market. Stringent device licensing regulations and a wide choice of electrical stimulation system alternatives are the factors the market is expected to get hampered in the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic is the most devastating health crisis that humanity has faced in the last century. The lack of viable medicinal options has hampered the fight against the disease. Based on solid research findings, electric stimulation can be a viable adjuvant to currently utilized symptomatic therapy and antiviral medications. Based on preclinical studies, electric stimulation can improve respiratory functions, limit SARS-CoV-2 growth, alleviate pain, raise immunity, and improve antiviral medication penetration. Furthermore, NMES is a simple and non-invasive therapy for muscle strengthening that is generally well tolerated, produces no adverse effects, requires no or little assistance from patients, and is relatively inexpensive. As a result, demonstrating the efficacy of NMES therapy for physical and muscle function in COVID-19 patients may support its systematic inclusion in post-ICU rehabilitation protocols for patients with post-intensive care syndrome.

Segment Analysis

Pain Management segment is expected to hold the largest market share in electric stimulation devices market.

The pain management segment accounted for the largest market share in 2021. The segment benefits from the increasing prevalence of chronic pain disorders, and the growing usage of Pain Management products due to their high therapeutic advantages are the factors the market is driven in the forecast period. For instance, chronic pain is estimated to affect 11% to 40% of persons in the United States. The most prevalent chronic pain issue is low back pain. Women and people over the age of 65 are more prone to experience chronic pain. Chronic pain costs the United States up to $635 billion every year. Severe depression affects more than 8 out of 10 chronic pain patients. One in every four patients suffering from chronic pain has a sleep disturbance. Chronic pain affects at least 10% of the world's population. Therefore, the demand for electric stimulation devices for chronic pain has increased. Thus, from the above statements, the market segment accounted for the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global electric stimulation devices market

North America accounted for the largest market share in 2021. The rise in chronic pain, the prevalence of sports injuries, the rise in the geriatric population, and significant market competitors focused on obtaining FDA approval for novel products to treat patients are the factors the market is driven in the forecast period. For instance, in May 20, 2022, NeuroMetrix, Inc. announced that its wearable technology for chronic pain therapy had gained 510(k) approval (K140333) from the United States Food and Drug Administration (FDA) for over-the-counter usage. The company is nearing the end of developing a consumer-oriented chronic pain management product. The gadget is built on wearable technology, currently used in the Company's SENSUS Pain Management System, to induce safe and effective pain treatment by gentle, non-invasive electrical stimulation of sensory neurons. It is lightweight and can be worn throughout the day and while sleeping. Thus, for the statements, North America accounted for the largest market share in the forecast period.

Competitive Landscape

Major key players in the electric stimulation devices market are Boston Scientific Corporation, Cyberonics, Inc, Colfax Corporation (DJO Global, Inc.), Medtronic plc, Nevro Corporation, Abbott, NeuroMetrix, Inc., BTL Industries, Inc., Cogentix Medical Inc., Zynex Inc.

Boston Scientific Corporation:

Overview:

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices used in various interventional medical specialties. The company offers its products in businesses such as Interventional Cardiology, Peripheral Interventions, Cardiac Rhythm Management, Electrophysiology, Endoscopy, Urology and Pelvic Health, Neuromodulation and Specialty Pharmaceuticals. Moreover, it operates in three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. MedSurg consists of Endoscopy, Urology, and Pelvic Health businesses. The rhythm segment consists of Cardiac Rhythm Management, Electrophysiology and Neuromodulation businesses. Across 100+ countries, the company delivers care more effectively by reducing costs, increasing efficiencies, and expanding access to care to help more people live healthier lives.

Product Portfolio:

Precision Novi Primary Cell Spinal Cord Stimulator System: Precision Novi is the smallest, thinnest high, capacity primary cell spinal cord stimulator implant with a unique contoured shape. This improved implant shape was designed to enhance patient comfort and address the primary cause of revision surgeries: pain over the implant site.

The global electric stimulation devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Innovations in the nerve-stimulation device for paralyzed patients are expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. Stringent device licensing regulations are expected to hamper market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces
  • 5.2. Unmet Needs
  • 5.3. Supply Chain
  • 5.4. Pricing Analysis
  • 5.5. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Device Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 7.1.2. Market Attractiveness Index, By Device Type
  • 7.2. Spinal Cord Stimulation Devices*
      • 7.2.1.1. Introduction
      • 7.2.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Deep Brain Stimulation Devices
  • 7.4. Vagus Nerve Stimulation Devices
  • 7.5. Sacral Nerve Stimulation Devices
  • 7.6. Gastric Electric Stimulation Devices
  • 7.7. Transcutaneous Electrical Nerve Stimulation Devices
  • 7.8. Neuromuscular Electrical Stimulation Devices
  • 7.9. Cranial Electrical Stimulation Devices
  • 7.10. Others

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pain Management*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Neurological and Movement Disorder Management
  • 8.4. Musculoskeletal Disorder Management
  • 8.5. Metabolism & GIT Management
  • 8.6. Incontinence Management
  • 8.7. Others

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Specialty Clinics
  • 9.4. Neurosurgical Centers
  • 9.5. Ambulatory Surgical Centers
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Device Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Boston Scientific Corporation*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cyberonics, Inc
  • 12.3. Colfax Corporation (DJO Global, Inc.)
  • 12.4. Medtronic plc
  • 12.5. Nevro Corporation
  • 12.6. Abbott
  • 12.7. NeuroMetrix, Inc.
  • 12.8. BTL Industries, Inc.
  • 12.9. Cogentix Medical Inc.
  • 12.10. Zynex Inc.

LIST NOT EXHAUSTIVE

13. Global Electric Stimulation Devices Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us